2-chloroadenosine has been researched along with n(6)-cyclopentyladenosine in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (14.29) | 18.7374 |
1990's | 28 (66.67) | 18.2507 |
2000's | 7 (16.67) | 29.6817 |
2010's | 1 (2.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berkich, DA; Dean, RL; Eveleth, D; Hiramatsu, K; Jacobson, KA; Ji, XD; Kassell, NF; Lee, KS; Nikodijevic, O; van Galen, PJ | 1 |
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
Daly, JW; Olsson, RA; Secunda, S; Thompson, RD | 1 |
Contardo, N; deJesus, R; Dotson, R; Francis, JE; Ghai, GR; Hutchison, AJ; Moskal, MA; Rovinski, SL; Webb, RL; Yokoyama, R | 1 |
Arroyo, LH; Olsson, RA; Thompson, RD; Ueeda, M | 1 |
Bruns, RF; Trivedi, BK | 1 |
Bruns, RF; Moos, WH; Szotek, DS | 1 |
Bristol, JA; Bruns, RF; Haleen, SJ; Steffen, RP; Trivedi, BK | 1 |
Bertin, B; Freissmuth, M; Hohenegger, M; Jockers, R; Linder, ME; Marullo, S; Nanoff, C; Strosberg, AD | 1 |
Jacobson, KA; Ji, XD; Kim, HO; Olah, ME; Siddiqi, SM; Stiles, GL | 1 |
Cappellacci, L; Franchetti, P; Grifantini, M; Lucacchini, A; Marchetti, S; Martini, C; Mazzoni, MR; Trincavelli, L | 1 |
Barbhaiya, H; IJzerman, AP; Rivkees, SA | 1 |
Figler, H; Jin, X; Linden, J; Robeva, AS; Thai, T | 1 |
Barak, D; Biadatti, T; Chen, W; Gao, ZG; Jacobson, KA; Johnson, CR; Kim, SG; Kim, SK; Lee, K | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Földes, FF; Nagano, O; Nakatsuka, H; Ohta, Y; Reich, D; Sperlagh, B; Vizi, ES | 1 |
Evans, DH | 1 |
Amerini, S; Ledda, F; Mantelli, L; Rubino, A | 1 |
Do, UH; Jarvis, MF; Sills, MA; Williams, M | 1 |
Lothman, EW; Stringer, JL | 1 |
Blair, TA; Murray, TF; Parenti, M | 1 |
Coffin, VL; Spealman, RD | 2 |
Burnstock, G; Ralevic, V; Rubino, A | 1 |
Hill, SJ; Peakman, MC | 1 |
Belloni, FL; Hernandez, A; Lee, HT; Lewy, JL; Thompson, CI | 1 |
Dickenson, JM; Hill, SJ; Megson, AC; Townsend-Nicholson, A | 1 |
Broad, RM; Fredholm, BB | 1 |
Hettinger-Smith, BD; Leid, M; Murray, TF | 1 |
Clotz, MA; Haun, SE; Horrocks, LA; Segeleon, JE; Trapp, VL | 1 |
Atmaca, M; Fry, JR | 1 |
Chopde, CT; Ghosh, AK; Mandhane, SN | 1 |
Buxton, IL; Cheek, DJ; Smith, AD; Westfall, DP | 1 |
Neher, M; Schneider, A; Schwaninger, M; Spranger, M; Viegas, E | 1 |
Koch, H; Starke, K; von Kügelgen, I | 1 |
Keef, KD; Mutafova-Yambolieva, VN | 1 |
Georgiev, V; Kambourova, T; Tchekalarova, J | 1 |
Abebe, W; Mozaffari, MS | 1 |
Fragata, IR; Ribeiro, JA; Sebastião, AM | 1 |
Kubota, Y; Kunitomo, M; Mizuno, H; Morikawa, T; Nakamura, K; Shinozuka, K; Tanaka, N | 1 |
1 review(s) available for 2-chloroadenosine and n(6)-cyclopentyladenosine
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
41 other study(ies) available for 2-chloroadenosine and n(6)-cyclopentyladenosine
Article | Year |
---|---|
Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists.
Topics: Adenosine; Animals; Body Temperature; Brain; Evoked Potentials; Gerbillinae; In Vitro Techniques; Lipolysis; Male; Mice; Motor Activity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Solubility; Structure-Activity Relationship; Sulfonic Acids | 1992 |
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
Topics: 2-Chloroadenosine; Animals; Brain; In Vitro Techniques; Rats; Receptors, Purinergic; Structure-Activity Relationship | 1991 |
Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines.
Topics: Adenosine; Alkylation; Animals; Antihypertensive Agents; Blood Pressure; Chemical Phenomena; Chemistry; Cyclohexanes; Heart Rate; Hypertension; Male; Molecular Structure; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Purinergic | 1991 |
2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
Topics: Adenosine; Animals; Atrioventricular Node; Coronary Vessels; Guinea Pigs; Heart; In Vitro Techniques; Models, Molecular; Molecular Conformation; Molecular Structure; Muscle, Smooth, Vascular; Rats; Receptors, Purinergic; Structure-Activity Relationship | 1991 |
C2,N6-disubstituted adenosines: synthesis and structure-activity relationships.
Topics: Adenosine; Animals; Binding, Competitive; Chemical Phenomena; Chemistry; Rats; Receptors, Purinergic; Structure-Activity Relationship | 1989 |
N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists.
Topics: Adenosine; Animals; Kinetics; Rats; Receptors, Cell Surface; Receptors, Purinergic; Structure-Activity Relationship | 1985 |
N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.
Topics: Adenosine; Animals; Brain; Cell Membrane; Coronary Circulation; Fluorenes; Heart Rate; In Vitro Techniques; Indicators and Reagents; Kinetics; Rats; Receptors, Purinergic; Structure-Activity Relationship | 1988 |
Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor.
Topics: Animals; Base Sequence; Brain; Cattle; DNA Primers; Escherichia coli; GTP-Binding Proteins; Humans; Molecular Sequence Data; Protein Binding; Receptors, Purinergic P1; Recombinant Proteins; Species Specificity | 1994 |
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Brain; Cell Membrane; CHO Cells; Cricetinae; Molecular Structure; Rats; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship | 1994 |
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Animals; Brain; Cattle; Enzyme Inhibitors; In Vitro Techniques; Male; Membranes; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Testis | 1998 |
Identification of the adenine binding site of the human A1 adenosine receptor.
Topics: Adenine; Amides; Amino Acid Sequence; Amino Acids; Binding Sites; DNA, Complementary; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Receptors, Purinergic P1 | 1999 |
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines | 1999 |
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Topics: Adenosine; Animals; Binding, Competitive; CHO Cells; Cricetinae; Epoxy Compounds; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Models, Molecular; Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Ribose; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship | 2002 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation.
Topics: 2-Chloroadenosine; Acetylcholine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Diaphragm; Dipyridamole; Electric Stimulation; In Vitro Techniques; Magnesium; Male; Mice; Muscle Contraction; Neuromuscular Junction; Phrenic Nerve; Purinergic Antagonists; Receptors, Purinergic; Synapses; Synaptic Transmission; Theophylline; Tritium; Tubocurarine; Xanthines | 1992 |
Evidence for the presence of A1 and A2 adenosine receptors in the ventral aorta of the dogfish shark, Squalus acanthias.
Topics: 2-Chloroadenosine; Adenosine; Animals; Aorta; Dogfish; Dose-Response Relationship, Drug; Muscle, Smooth, Vascular; Phenylisopropyladenosine; Receptors, Purinergic | 1992 |
Adenosine receptors involved in the inhibitory control of non-adrenergic non-cholinergic neurotransmission in guinea-pig atria belong to the A1 subtype.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Atrial Function; Autonomic Nervous System; Electric Stimulation; Guinea Pigs; Heart; In Vitro Techniques; Male; Neurons, Afferent; Phenylisopropyladenosine; Receptors, Purinergic; Reserpine; Synaptic Transmission; Theophylline | 1991 |
Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.
Topics: 2-Chloroadenosine; Adenosine; Animals; Binding, Competitive; Cerebral Cortex; Dose-Response Relationship, Drug; Phenylisopropyladenosine; Purinergic Antagonists; Pyrazoles; Quinazolines; Rats; Receptors, Purinergic; Triazoles; Tritium | 1991 |
A1 adenosinergic modulation alters the duration of maximal dentate activation.
Topics: 2-Chloroadenosine; Adenosine; Animals; Electric Stimulation; Hippocampus; Limbic System; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic; Seizures; Time Factors; Xanthines | 1990 |
Development of pharmacological sensitivity to adenosine analogs in embryonic chick heart: role of A1 adenosine receptors and adenylyl cyclase inhibition.
Topics: 2-Chloroadenosine; Adenosine; Adenylyl Cyclase Inhibitors; Animals; Chick Embryo; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Heart Rate; Potassium Channels; Receptors, Muscarinic; Receptors, Purinergic | 1989 |
Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Discrimination Learning; Drug Interactions; Male; Phenylisopropyladenosine; Receptors, Purinergic; Saimiri; Stereoisomerism | 1988 |
Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Blood Pressure; Caffeine; Cardiovascular System; Clonidine; Cocaine; Dextroamphetamine; Heart Rate; Isomerism; Macaca fascicularis; Male; Phenylisopropyladenosine | 1987 |
Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Antihypertensive Agents; Arginine; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Male; Mesenteric Arteries; Methoxamine; NG-Nitroarginine Methyl Ester; Phenethylamines; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Theophylline; Thionucleotides; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1995 |
Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Astrocytes; Cells, Cultured; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Immunohistochemistry; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1994 |
Cardiac desensitization to adenosine analogues after prolonged R-PIA infusion in vivo.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Carbachol; Down-Regulation; GTP-Binding Proteins; Heart; Heart Atria; In Vitro Techniques; Male; Myocardium; Phenylisopropyladenosine; Rats; Rats, Wistar; Receptors, Purinergic P1; Time Factors | 1993 |
Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cattle; Cells, Cultured; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Humans; Inositol Phosphates; Pertussis Toxin; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Uridine Triphosphate; Virulence Factors, Bordetella; Xanthines | 1995 |
A1, but not A2A, adenosine receptors modulate electrically stimulated [14C]acetylcholine release from rat cortex.
Topics: 2-Chloroadenosine; Acetylcholine; Adenosine; Animals; Cerebral Cortex; Electric Stimulation; In Vitro Techniques; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Xanthines | 1996 |
Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells.
Topics: 2-Chloroadenosine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adenylyl Cyclases; Animals; Binding, Competitive; Cell Membrane; Cerebellum; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Kinetics; Neurons; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Theophylline; Time Factors; Xanthines | 1996 |
Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Animals, Newborn; Astrocytes; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Glucose; Inosine; Kinetics; L-Lactate Dehydrogenase; Purines; Rats; Rats, Sprague-Dawley | 1996 |
Adenosine-mediated inhibition of glutathione synthesis in rat isolated hepatocytes.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Animals; Glucose; Glutathione; In Vitro Techniques; Liver; Male; Methionine; Rats; Rats, Wistar; Receptors, Purinergic P1; Vitamin K | 1996 |
Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Scopolamine; Theobromine; Theophylline; Xanthines | 1997 |
Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
Topics: 2-Chloroadenosine; Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding Sites; Binding, Competitive; In Vitro Techniques; Kinetics; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vas Deferens; Xanthines | 1997 |
Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine.
Topics: 2-Chloroadenosine; Adenosine; Animals; Animals, Newborn; Astrocytes; Cerebral Cortex; Genes, Reporter; Humans; Interleukin-6; Kinetics; Mice; Phenethylamines; Purinergic P1 Receptor Agonists; Recombinant Fusion Proteins; Transcription, Genetic | 1997 |
P2-receptor-mediated inhibition of serotonin release in the rat brain cortex.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cerebral Cortex; Desipramine; Dinucleoside Phosphates; In Vitro Techniques; Male; Methiothepin; Quipazine; Rats; Rats, Wistar; Receptors, Purinergic P2; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1997 |
Adenosine-induced hyperpolarization in guinea pig coronary artery involves A2b receptors and KATP channels.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cell Membrane; Coronary Vessels; Endothelium, Vascular; Glyburide; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Membrane Potentials; Nitroarginine; Potassium Channels; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2B; Receptors, Purinergic P1 | 1997 |
Interaction between angiotensin IV and adenosine A(1) receptor related drugs in passive avoidance conditioning in rats.
Topics: 2-Chloroadenosine; Adenosine; Angiotensin II; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraventricular; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline | 2001 |
Effect of taurine deficiency on adenosine receptor-mediated relaxation of the rat aorta.
Topics: 2-Chloroadenosine; Acetylcholine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Aorta, Thoracic; beta-Alanine; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Rats; Rats, Inbred WKY; Receptors, Purinergic P1; Taurine; Triazines; Triazoles; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
Topics: 2-Chloroadenosine; Adenosine; Animals; Bicuculline; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; GABA Antagonists; gamma-Aminobutyric Acid; Guanylate Cyclase; Hippocampus; In Vitro Techniques; Male; Neural Inhibition; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Penicillamine; Quinoxalines; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, GABA-A; Synaptic Transmission | 2006 |
ATP modulates the release of noradrenaline through two different prejunctional receptors on the adrenergic nerves of rat prostate.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Male; Norepinephrine; Presynaptic Terminals; Prostate; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Presynaptic; Receptors, Purinergic P2; Suramin; Sympathetic Nervous System; Thionucleotides; Xanthines | 2007 |